Cargando…

Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk

BACKGROUND: Thymic stromal Lymphopoeitin (TSLP) is a key cytokine involved in inflammation and cancer progression. TSLP gene polymorphisms have been associated with increased susceptibility to cancer progression in different organs. We performed a control case study to examine the correlation of exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Semlali, Abdelhabib, Almutairi, Mikhlid, Reddy Parine, Narasimha, Al Amri, Abdullah, Almeer, Rafa, Alanazi, Mohammad S., Rouabhia, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687655/
https://www.ncbi.nlm.nih.gov/pubmed/31210014
http://dx.doi.org/10.1002/mgg3.813
_version_ 1783442749670817792
author Semlali, Abdelhabib
Almutairi, Mikhlid
Reddy Parine, Narasimha
Al Amri, Abdullah
Almeer, Rafa
Alanazi, Mohammad S.
Rouabhia, Mahmoud
author_facet Semlali, Abdelhabib
Almutairi, Mikhlid
Reddy Parine, Narasimha
Al Amri, Abdullah
Almeer, Rafa
Alanazi, Mohammad S.
Rouabhia, Mahmoud
author_sort Semlali, Abdelhabib
collection PubMed
description BACKGROUND: Thymic stromal Lymphopoeitin (TSLP) is a key cytokine involved in inflammation and cancer progression. TSLP gene polymorphisms have been associated with increased susceptibility to cancer progression in different organs. We performed a control case study to examine the correlation of expression and polymorphisms of three nucleotides in TSLP with breast cancer (BC) risk in Saudi Arabian females. MATERIALS AND METHODS: The study was conducted on 116 healthy control subjects and 127 female patients with BC for the purpose of genotyping. Ten matching tissues provided data on immunohistochemistry to evaluate TSLP expression. Three SNPs (rs10043985, rs2289276, and rs3806933) were genotyped with TaqMan allelic discrimination assay. The patients' ages and estrogen receptor statuses were used to investigate the potential correlations between the different variations of TSLP genotypes and BC risk. RESULTS: BC tissues expressed positive immuno‐staining for TSLP at a high rate compared to normal matching breast tissues. Malignant breast tumors exhibited higher TSLP expression than benign breast tumors. We also found that the rs3806933 (T) allele frequency decreased the risk of developing BC in the study population (OR = 0.356, p = 0.00027) significantly (0.356 times). Interestingly, statistical analysis revealed that the genotype mutant (AC) and the allele mutant (C) of rs10043985 within TSLP were significantly correlated with an increased BC risk (odds ratio [OR] = 4.762, confidence interval [CI] = 1.000–22.666, p = 0.03244; OR = 4.762, CI = 1.000–22.666, p = 0.03244; and OR = 4.575, CI = 0.975–21.464, p = 0.03516, respectively). In addition, the AC and AC + CC genotypes of TSLP rs10043985 were confirmed to be associated with an increased risk of BC risk in women aged above 48 years, compared with the AA genotype (AC and AC + CC vs. AA: OR = 9.468, CI = 0.493–181.768, p = 0.04537). CONCLUSION: The results reveal significant correlation between SNPs in TSLP and BC progression in Saudi Arabian female patients.
format Online
Article
Text
id pubmed-6687655
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66876552019-08-14 Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk Semlali, Abdelhabib Almutairi, Mikhlid Reddy Parine, Narasimha Al Amri, Abdullah Almeer, Rafa Alanazi, Mohammad S. Rouabhia, Mahmoud Mol Genet Genomic Med Original Articles BACKGROUND: Thymic stromal Lymphopoeitin (TSLP) is a key cytokine involved in inflammation and cancer progression. TSLP gene polymorphisms have been associated with increased susceptibility to cancer progression in different organs. We performed a control case study to examine the correlation of expression and polymorphisms of three nucleotides in TSLP with breast cancer (BC) risk in Saudi Arabian females. MATERIALS AND METHODS: The study was conducted on 116 healthy control subjects and 127 female patients with BC for the purpose of genotyping. Ten matching tissues provided data on immunohistochemistry to evaluate TSLP expression. Three SNPs (rs10043985, rs2289276, and rs3806933) were genotyped with TaqMan allelic discrimination assay. The patients' ages and estrogen receptor statuses were used to investigate the potential correlations between the different variations of TSLP genotypes and BC risk. RESULTS: BC tissues expressed positive immuno‐staining for TSLP at a high rate compared to normal matching breast tissues. Malignant breast tumors exhibited higher TSLP expression than benign breast tumors. We also found that the rs3806933 (T) allele frequency decreased the risk of developing BC in the study population (OR = 0.356, p = 0.00027) significantly (0.356 times). Interestingly, statistical analysis revealed that the genotype mutant (AC) and the allele mutant (C) of rs10043985 within TSLP were significantly correlated with an increased BC risk (odds ratio [OR] = 4.762, confidence interval [CI] = 1.000–22.666, p = 0.03244; OR = 4.762, CI = 1.000–22.666, p = 0.03244; and OR = 4.575, CI = 0.975–21.464, p = 0.03516, respectively). In addition, the AC and AC + CC genotypes of TSLP rs10043985 were confirmed to be associated with an increased risk of BC risk in women aged above 48 years, compared with the AA genotype (AC and AC + CC vs. AA: OR = 9.468, CI = 0.493–181.768, p = 0.04537). CONCLUSION: The results reveal significant correlation between SNPs in TSLP and BC progression in Saudi Arabian female patients. John Wiley and Sons Inc. 2019-06-17 /pmc/articles/PMC6687655/ /pubmed/31210014 http://dx.doi.org/10.1002/mgg3.813 Text en © 2019 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Semlali, Abdelhabib
Almutairi, Mikhlid
Reddy Parine, Narasimha
Al Amri, Abdullah
Almeer, Rafa
Alanazi, Mohammad S.
Rouabhia, Mahmoud
Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk
title Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk
title_full Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk
title_fullStr Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk
title_full_unstemmed Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk
title_short Expression and allele frequencies of Thymic stromal lymphopoietin are a key factor of breast cancer risk
title_sort expression and allele frequencies of thymic stromal lymphopoietin are a key factor of breast cancer risk
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687655/
https://www.ncbi.nlm.nih.gov/pubmed/31210014
http://dx.doi.org/10.1002/mgg3.813
work_keys_str_mv AT semlaliabdelhabib expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk
AT almutairimikhlid expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk
AT reddyparinenarasimha expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk
AT alamriabdullah expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk
AT almeerrafa expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk
AT alanazimohammads expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk
AT rouabhiamahmoud expressionandallelefrequenciesofthymicstromallymphopoietinareakeyfactorofbreastcancerrisk